Welcome to my channel I'm Tomas and this is my author channel and in today's video I'll show you BMW M4 CSL by MC Max Carbon! Supreme Court Is Told Trump Tariffs Are Illegal $3 Trillion Tax Georgia ...

A rare 2023 BMW M4 CSL with only 1,600 miles is up for sale on Bring a Trailer. This lightweight, high-performance coupe looks almost new and demands attention. The Ultimate Driving Machine never ...

The exit delivers a 3.5x return CSL has grown around 20% annually ECI first invested in CSL in 2020 ECI Partners has exited CSL, a critical IoT connectivity business, into a continuation fund, ...

CSL's shares dropped significantly after announcing weaker FY 2026 guidance and plans to demerge its Seqirus segment. The company's ambitious restructuring involves workforce reductions and aims for ...

Gift 5 articles to anyone you choose each month when you subscribe. CSL chief financial officer Joy Linton retired on Tuesday. That’s the big Australian biotech trying to change the story. Something ...

CSL has partnered with Dutch biotech VarmX to co-develop VMX-C001, a potential first-in-class treatment to restore blood coagulation in patients on FXa inhibitors. The agreement includes an upfront ...

CSL has moved quickly to spend some of the money freed up by recent cuts, securing an option to buy the phase 3-ready blood clotting specialist VarmX in return for $117 million upfront. Last month, ...

CSL pays $117 million for exclusive option to acquire VarmX VarmX could receive up to $388 million if milestones are met CSL funds VarmX's Phase 3 trial for VMX-C001 Sept 16 (Reuters) - Australia's ...

CSL will invest up to $760 million in Dutch biotech VarmX, marking the healthcare giant’s first major investment since it announced 3000 job cuts and plans to scale back its global research and ...

ADRs of CSL Limited (OTCQX:CSLLY) dropped ~16% on Tuesday as Wall Street reacted to Australian biotech’s plans to lay off 15% of its workforce, announced in conjunction with its fiscal 2025 financials ...

Thank you for standing by, and welcome to the CSL Limited Full Year Financial Results. [Operator Instructions] I would now like to hand the conference over to Mr. Chris Cooper, Head of Investor ...

Aug 19 (Reuters) - Australian biotech giant CSL (CSL.AX), opens new tab said on Tuesday it plans to demerge its influenza vaccine division, CSL Seqirus, into a separately listed company by the end of ...